194 related articles for article (PubMed ID: 11435315)
1. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria.
Holt DS; Botto M; Bygrave AE; Hanna SM; Walport MJ; Morgan BP
Blood; 2001 Jul; 98(2):442-9. PubMed ID: 11435315
[TBL] [Abstract][Full Text] [Related]
2. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
3. Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.
Hill A; Ridley SH; Esser D; Oldroyd RG; Cullen MJ; Kareclas P; Gallagher S; Smith GP; Richards SJ; White J; Smith RA; Hillmen P
Blood; 2006 Mar; 107(5):2131-7. PubMed ID: 16322479
[TBL] [Abstract][Full Text] [Related]
4. Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis.
Babiker AA; Ronquist G; Nilsson UR; Nilsson B
Am J Reprod Immunol; 2002 Mar; 47(3):183-92. PubMed ID: 12069204
[TBL] [Abstract][Full Text] [Related]
5. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.
Mevorach D
Mol Immunol; 2015 Sep; 67(1):51-5. PubMed ID: 25818314
[TBL] [Abstract][Full Text] [Related]
6. Correction of the PNH defect by GPI-anchored protein transfer.
Sloand EM; Maciejewski JP; Dunn D; Moss J; Brewer B; Kirby M; Young NS
Blood; 1998 Dec; 92(11):4439-45. PubMed ID: 9834251
[TBL] [Abstract][Full Text] [Related]
7. CD59a is the primary regulator of membrane attack complex assembly in the mouse.
Baalasubramanian S; Harris CL; Donev RM; Mizuno M; Omidvar N; Song WC; Morgan BP
J Immunol; 2004 Sep; 173(6):3684-92. PubMed ID: 15356114
[TBL] [Abstract][Full Text] [Related]
8. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.
Hall SE; Rosse WF
Blood; 1996 Jun; 87(12):5332-40. PubMed ID: 8652849
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the complement sensitivity of calcium loaded human erythrocytes.
Test ST; Bütikofer P; Yee MC; Kuypers FA; Lubin B
Blood; 1991 Dec; 78(11):3056-65. PubMed ID: 1720041
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.
Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ
Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516
[TBL] [Abstract][Full Text] [Related]
11. Balancing role of nitric oxide in complement-mediated activation of platelets from mCd59a and mCd59b double-knockout mice.
Qin X; Hu W; Song W; Blair P; Wu G; Hu X; Song Y; Bauer S; Feelisch M; Leopold JA; Loscalzo J; Halperin JA
Am J Hematol; 2009 Apr; 84(4):221-7. PubMed ID: 19229985
[TBL] [Abstract][Full Text] [Related]
12. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
Hatanaka M; Inai S; Matsumoto M; Miyagawa S; Masaoka T; Kanamaru A; Kawakita M; Yonemura Y; Sugita Y; Seya T
Clin Immunol Immunopathol; 1993 Oct; 69(1):52-9. PubMed ID: 7691453
[TBL] [Abstract][Full Text] [Related]
13. CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy.
Nevo Y; Ben-Zeev B; Tabib A; Straussberg R; Anikster Y; Shorer Z; Fattal-Valevski A; Ta-Shma A; Aharoni S; Rabie M; Zenvirt S; Goldshmidt H; Fellig Y; Shaag A; Mevorach D; Elpeleg O
Blood; 2013 Jan; 121(1):129-35. PubMed ID: 23149847
[TBL] [Abstract][Full Text] [Related]
14. Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation.
Nakakuma H; Hidaka M; Nagakura S; Nishimura Y; Iwamoto N; Horikawa K; Kawaguchi T; Kagimoto T; Takatsuki K
J Clin Invest; 1995 Jul; 96(1):201-6. PubMed ID: 7542278
[TBL] [Abstract][Full Text] [Related]
15. Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria.
Merrill SA; Brodsky RA
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):371-376. PubMed ID: 30504334
[TBL] [Abstract][Full Text] [Related]
16. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria.
Wiedmer T; Hall SE; Ortel TL; Kane WH; Rosse WF; Sims PJ
Blood; 1993 Aug; 82(4):1192-6. PubMed ID: 7688991
[TBL] [Abstract][Full Text] [Related]
17. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
Yuan FF; Bryant JA; Fletcher A
Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of complement derived from the erythrocyte membrane in paroxysmal nocturnal hemoglobinuria.
Chua C; Hoffmann EM; Adams JP; Rosse WF
Blood; 1980 May; 55(5):772-6. PubMed ID: 7362868
[TBL] [Abstract][Full Text] [Related]
19. Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation.
Test ST; Woolworth VS
Blood; 1994 Feb; 83(3):842-52. PubMed ID: 7507737
[TBL] [Abstract][Full Text] [Related]
20. H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement.
Whitlow MB; Iida K; Stefanova I; Bernard A; Nussenzweig V
Cell Immunol; 1990 Mar; 126(1):176-84. PubMed ID: 1689219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
